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Abstract
Background: Intraoperative neurophysiology, high magnification microscopes,
and ultrasonic aspirators are considered essential aid for the safe resection of
intramedullary spinal cord tumors (IMSCTs). Most centers in developing countries
such as Pakistan still lack these facilities. The purpose of this study was to review
the management of IMSCTs at our hospital and to determine factors associated
with the outcomes of surgery.
Methods: This was a retrospective review of medical records of adult patients
undergoing surgery for IMSCT over 12 years. The institutional ethical review
committee approved this study. Data were collected regarding demographics,
clinical and radiological features, and surgical details. Modified McCormick Scale
was used to grade patients’ neurological status at admission, discharge, and
follow‑up. Statistical analysis was performed using the Statistical Package for
Social Sciences version 22.
Results: Forty three cases were reviewed. Mean age was 33.8 ± 15.1 years
whereas median follow‑up was 5 months (range: 0.25–96 months). Most
patients had ependymoma (n = 16; 73%). Cervical region was the most
commonly involved (n = 15; 34.9%). Gross total resection (GTR) was achieved in
30 cases (69.8%). The preoperative McCormick grade was significantly associated
with follow‑up McCormick grade (P value = 0.002). Eight patients (18.6%) underwent
intraoperative electrophysiological monitoring, out of which GTR was achieved in
all cases, and none had disease progression or recurrence. Ten patients received
postoperative radiotherapy. Thirty five patients (81.4%) had progression free
survival at last follow‑up.
Conclusions: We achieved a GTR rate of 68.9% for IMSCTs with limited resources.
In few cases, where intraoperative electrophysiology was used, the rate of GTR was
100%. Preoperative neurological status was associated with better postoperative
McCormick score.
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INTRODUCTION
Intramedullary spinal cord tumors (IMSCT) account for
only 4–10% of all primary central nervous system (CNS)
neoplastic lesions and 20% of all spinal cord tumors
in adults.[8] Although uncommon, IMSCTs can cause
disability and severely affect the quality of life.[8,11]
Spinal ependymoma is the most frequently occurring
IMSCT.[8,11] Magnetic resonance imaging (MRI) is
the imaging modality of choice for the diagnosis and
characterization of these lesions.[20]
According to previous studies regarding treatment options,
early surgical excision, possibly gross total resection
(GTR), improves functional outcomes.[11,16,18] Numerous
authors have endorsed regular use of intraoperative
electrophysiological monitoring (IOEM) including
somatosensory‑evoked
potentials
(SSEP)
and
motor‑evoked potentials (MEP); however, there is
insufficient evidence assessing their real impact on
functional outcomes.[6,9,14,17]
There is scarcity of data on IMSCT from Pakistan[1]
and other countries from South Asia, where performing
maximum resection of tumor becomes even more
challenging due to resource limitations. The purpose of
this study was to review the presentation, management,
and outcomes IMSCTs at our hospital during last
12 years and to determine the factors associated with
outcomes of surgery.

MATERIALS AND METHODS
This was a retrospective review. All patients who
underwent surgery for IMSCT at our hospital between
2003 and 2015 with complete records available,
irrespective of age and gender, were included. The
patients were identified by the Medical Records
department of the hospital, which then retrieved their
medical records. Ethical approval was obtained from
the Ethical Review Committee at Aga Khan University
Hospital, Karachi (3533‑Sur‑ERC‑15).
Data was collected according to a proforma. It consisted
of different variables including demographics, clinical
presentation of disease and management in the hospital,
histopathological diagnosis, and postoperative course of
the disease. This information was extracted by reviewing
patients’ medical records. Patients with incomplete
records were excluded from the study.
GTR was defined as the removal of >95% tumor tissue,
which was either mentioned in operative notes or seen on
postoperative MRI. Maximum safe resection (MSR) was
defined as the removal of maximum volume of tissue,
which could be safely removed. Biopsy was defined as
the removal of only a small amount of tissue required for
histological analysis.
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Use of IOEM is not a standard practice at our hospital
so it was utilized in some cases using SSEP. Tumor was
histologically diagnosed and then graded according to the
World Health Organization (WHO) classification at the
histopathology department of our hospital. Progression
free survival (PFS) was defined as no recurrence of
disease after GTR and no increase in the size of residual
disease after MSR or biopsy.
Modified McCormick Scale (MMS) was used for grading
patients’ neurological status at admission, immediately
after surgery and at last follow‑up [Table 1].[13]

Surgical technique for intramedullary spinal
cord tumors
We perform the procedure in prone position under general
anesthesia. For cervical surgeries, Mayfield clamp is used
to fix the head in a flexed position. It is ensured that
abdomen is free and all the pressure points are adequately
padded. We confirm the level of surgery with the help of
fluoroscope before starting incision and after exposure of
laminae. For cases where intraoperative electrophysiology
monitoring is planned, electrodes are placed after
positioning. A midline posterior approach is used with
subperiosteal dissection to expose laminae bilaterally.
Facet joints are carefully preserved. Laminectomy is
performed at the level of the tumor, ensuring that we
have an adequate exposure of cranial and caudal limits
of the tumor. In few cases, we have also performed
laminoplasty without compromising exposure. After
extradural hemostasis, a midline durotomy is performed
using hook and knife. Posterior median sulcus is then
identified and gently opened to access the tumor. We
do not use coagulation and stay within the limits of the
tumor performing internal debulking with the help of
dissector and tumor forceps. After limited debulking, we
dissect the tumor from margins and roll it inward.

Once the dissection is completed till the normal cord
we complete the hemostasis. We use surgical (fibrillar
and other) instead of cotton balls. Our use of cavitron
ultrasonic surgical aspirator (CUSA) is very limited
because of the high cost associated with its disposables.
SSEP monitoring is not used consistently. Dura is closed
in a watertight fashion using nonabsorbable suture.
Valsalva maneuver is performed to look for any leak.
Wound is then closed in layers.
Table 1: Modified McCormick scale
Grade

Modified McCormick Scale

I
II
III

Intact neurologically, normal ambulation, minimal dysesthesia
Mild motor or sensory deficit, functional independence
Moderate deficit, limitation of function, independent with
external aid
Severe motor or sensory deficit, limited function, dependent
Paraplegia or quadriplegia, even with flickering movement

IV
V

SNI: Neuro-Oncology 2016, Vol 7, Suppl 23 - A Supplement to Surgical Neurology International

Statistical analysis

Statistical Analysis was done using Statistical Package
for Social Sciences (SPSS Inc., Chicago, IL, USA.
Version 22.0). Means and standard deviation were calculated
for continuous data with normal distribution whereas
median and interquartile range (IQR) were calculated for
continuous data with skewed distribution. Percentages and
proportions were calculated for categorical data. Fisher’s
exact test was used to compare categorical data. Preoperative
neurological status, tumor histology, extent of resection,
and IOEM were correlated with postoperative neurological
outcome. Kaplan–Meier graph was plotted to portray PFS.

RESULTS
Forty three patients were included in the study. Median
age was 33.2 years, and the most common presenting
complaint was back pain present in 24 patients (55.8%).
The most common location was cervical spine (n = 15;
34.9) Only 3 patients (7.0%) had single level disease
and half of the patients had their disease involving 2 or
3 spinal levels (n = 22; 51.1%). The highest numbers
of disease levels involved were 7 present in 2 (4.7%)
patients. The most common histological diagnosis
was ependymoma. Patients’ demographics and clinical
characteristics are shown in Table 2.
We performed GTR in 30 patients (69.8%).
Intraoperative electrophysiological monitoring (IOEM)
was used in 8 (18.6%) patients and GTR was achieved
in all of them. Twenty nine (67.4%) patients had one
or more postoperative MRI done. Ten patients (23.3%)
received postoperative radiotherapy while none of the
patients received postoperative chemotherapy.

Neurological status

Postoperatively, 15 patients (34.9%) showed improvement
in their neurological function before discharge,
10 (23.2%) had transient worsening of function,
and 18 (41.9%) had no change. At last follow‑up, an
improvement in neurological function was observed
in 24 patients (55.8%), 15 (34.9%) maintained their
preoperative function, and only 4 patients (9.3%) had
persistently worsened neurological status. Graph 1 shows
that better pre‑operative MMS grades that resulted in
better neurological function postoperatively (P = <0.001)
and at last follow‑up (P = 0.002) [Graph 1].
Graph 2 depicts change in neurological status at
last follow‑up compared to the preoperative status,
and the role of IOEM, which was not statistically
significant (P = 0.456) [Graph 2].

Progression free survival

Eight patients (18.6%) had recurrence or progression
of disease after surgery. Only 3% of all the patients who
had GTR had disease progression, whereas 45% patients
with MSR and all patients with biopsy had disease

progression (P = 0.004). Thirty five patients (81.4%)
had progression free survival at last follow‑up. Table 3
shows some possible predictors of PFS.
Patients undergoing GTR had a significantly better
survival as compared to those who underwent MSR
or only biopsy on Kaplan–Meier log‑rank analysis
Table 2: Demographics and clinical characteristics
Demographics and Clinical Characteristics
Age (Median)
Gender
Male
Female
Comorbids
Hypertension
Diabetes mellitus
Ischemic heart disease
Benign prostatic hyperplasia
Length of hospital stay (Median)
Follow‑up time (Median)
Most common presenting complaint
Duration of symptoms (Median)
Location
Cervical
Thoracic
Lumbar
Cervicothoracic
Thoracolumbar
Operating time (Mean)
Commonest histological type of
tumor
Histology
Ependymoma
Astrocytoma
Oligodendroglioma
Hemangioblastoma
Ganglioglioma
Schwannoma
Extent of Resection
Gross total resection
Maximum safe resection
Biopsy

33.2 years (IQR=24-46 years)
n=27 (62.8%)
n=16 (37.8%
n=6 (14.0%)
n=2 (4.6%)
n=1 (2.3%)
n=1 (2.3%)
7 days (IQR=4-10 days)
5 months (IQR=2-15 months)
Backache
4 months (IQR=2-12 months)
n=15 (34.9%)
n=9 (20.9%)
n=9 (20.9%)
n=4 (9.3%)
n=6 (14.0%)
277.7±94.0 minutes
Ependymoma

n=26 (60%)
n=9 (21%)
n=2 (5%)
n=2 (5%)
n=1 (2%)
n=3 (7%)
n=30 (69.8%)
n=11 (25.6%)
n=2 (4.7%)

Table 3: Predictors of progression free survival
Predictors of Progression Free Survival
Factors
Age
Gender
Size of Lesion (>3 levels)
IOEM
GTR
Low grade lesion (Grade I/II)

P value
0.443
0.411
0.050
0.679
0.002
0.011
S619
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(P = <0.001), as shown in Figure 1. Similarly patients
who had lower histopathological grade (grade I/II) had a
better survival compared to those who had higher grades
of lesion (grade III/IV), as shown in Figure 2.

DISCUSSION
Lesions involving the spinal cord have always tested
surgeons’ skill. Figure 3 (a‑c) shows MRI scans of a
20‑year‑old girl who presented with progressive weakness
in all four limbs, more on the right side, for 2 years.
Her preoperative MMS was 3. She underwent cervical
laminectomy and gross total excision of the lesion 5 years
back. Her immediate postoperative MMS was 2, and at
last follow‑up after 4 years, it was 1. Last follow‑up scans
done 4 years after surgery are shown in Figure 4 (a‑c).
Last few years have seen major advances toward better
treatment of IMSCTs owing to developments in imaging
techniques and surgical procedures.[9,11,12] We studied
patients with IMSCT who were surgically treated at
30
25

25

Pre-op McCormick Grade
Post-op McCormick Grade

20

our hospital during last the 12 years; our sample of
43 patients is slightly less but comparable to most other
studies, although few studies with larger sample size have
been reported.[15,18] Our median follow‑up of 5 months is,
however, less than previous studies.[15,18]
Surgeons operating on IMSCTs are faced with the
predicament of attempting radical excision, and yet, preserve
adequate neural tissue. In a retrospective review conducted
in 2005 involving 78 patients, Sandalcioglu et al.[18] reported
that they achieved GTR in 83.3% patients and cited
preoperative neurological status as the most important
predicting factor of functional outcome. Similar findings
were quoted by Kumar et al.[10] in their study on 43 patients.
In another series of 70 cases, Bostrom et al.[2] also reported
complete removal in 64.3% cases and stated early GTR of
spinal ependymoma to be associated with better outcomes,
limiting role of MSR, or biopsy with adjuvant therapy for
high grade astrocytoma. We achieved GTR in 69.7% patients
and have also found statistically significant relationship
between preoperative and last follow‑up neurological
function. Because of less number of cases, subgroup analysis
for individual tumor types could not be done.
30
25

24

20

14

15

15

15

Last Follow-up McCormick
Grade

12

10

8
6

6
4

5

5
1

2

3

4

0
Grade I

Grade II

15
10

9

5

18
15

Grade III

Grade IV

Grade V

0

4

14

6
1

All patients

1

Patients with IOEM

Improvement in Neurological Status
No Change

3
Patients without IOEM

Deterioration in Neurological Status

Graph 1: McCormick grades on pre-operative, post-operative and
last follow up examination

Graph 2: Change in neurological status at last follow‑up and
intraoperative electrophysiological monitoring

Figure 1: Kaplan–Meier analysis for progression free survival with
gross resection rate, maximum safe resection, and biopsy

Figure 2: Kaplan–Meier analysis for progression free survival with
regards to grade of lesion
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b

a
a

b

c
Figure 3: (a) MRI cervical spine T2 weighted sagittal image showing
hyper-intense contrast enhancing lesion at C5-C7. (b) Magnetic
resonance imaging (MRI) cervical spine T1 weighted sagittal image
showing hyperintense lesion at C5-C7. (c) MRI T1 weighted axial
image showing large circumscribed hyper-intense lesion pushing
spinal cord to left side

In another study conducted in 2009, Matsuyama et al.[12]
included 106 patients with a wide age range of 6–75 years.
Their mean follow‑up period was 7.3 years. They reported
preoperative ambulatory status and GTR to be associated
with better neurological prognosis; however, they observed
postoperative neurological worsening in 31.5% patients.
This was higher as compared to our observation of
transient postoperative neurological deficits in 23.2%
patients. Only 11.6% of our patients developed permanent
neurological deficits after surgery at last follow‑up which
is better than most than other studies that observed
permanent deterioration in 11.6–34.6% patients.[2,10,12]
Management of tumors is always aimed at improving
PFS. We have reported recurrence or disease
progression in 18.6% patients, which is consistent
with the recurrence rates of 9–22% in the current
published literature.[2,10,18] Earlier studies have reported
high grade astrocytoma and malignant IMSCT
along with extent of resection to be associated with
increased risk of recurrence.[4,5] In our study, more
than half of the recurrences/disease progressions were
seen in astrocytoma, however, it was not statistically
significant (P = 0.308). We reported GTR and low
grade of lesion to be significant predictors of PFS,
which is in agreement with previous studies.[10,18]

c

Figure 4: (a) Post-operative MRI cervical spine T2 weighted sagittal
image showing thinning of spinal cord at C6. (b) Post-operative
MRI T2 weighted axial image showing thin spinal cord surrounded
by CSF. (c) MRI T2 weighted axial image showing normal section
of spinal cord

There is controversy in existing literature regarding
the role of adjuvant radiotherapy and chemotherapy
for IMSCT, with some latest studies limiting its role
to tumors which are not completely resectable.[3,7,18,19]
Approximately a quarter of our patients received adjuvant
radiotherapy and none received chemotherapy, however,
we did not find any significant impact of radiation
therapy on PFS or neurological outcomes.
The use of intraoperative electrophysiology techniques
including SSEP and/or MEP has been advocated to help
maintain patient’s neurological function after surgery,
which along with excision of entire tumor is the aim in
most procedures. In our study, IOEM was used in only
8 (18.6%) patients, 3 of which had temporary and 1
had permanent postoperative worsening of neurological
function. We did not observe any significant association
of IOEM with extent of surgical resection or preservation
of functional status. This is in contrast to studies at
other centers which used this modality more often and
attributed improved function due to its use improved
outcomes.[6,9,12,17] Our different findings may be due to
less often use of this modality and technical difficulties.
We included patients operated by multiple surgeons at a
single center and the follow‑up period was small, which
are important limitations of this study. Another important
feature is the impact of different anatomical levels of
disease on functional status, which was not found to be
statistically significant in our study, which again might be
due to the smaller number of study participants. However,
considering the rarity of these tumors and insufficient
data from developing countries, our study highlights
important aspects in the presentation, management and
outcomes of IMSCTs in our region.

CONCLUSION
We have achieved a GTR rate of 68.9% for IMSCTs
using limited technological assistance. In few cases,
S621
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where intraoperative electrophysiology was used, the rate
of GTR was 100%. Preoperative neurological status was
associated with better postoperative McCormick score.

9.

Financial support and sponsorship

10.

Nil.

Conflicts of interest

There are no conflicts of interest.

11.

12.

REFERENCES
1.

2.

3.

4.
5.

6.

7.
8.

Bhatti SN, Khan SA, Raja RA, Shah R, Aurangzeb A, Khan AA, et al. Outcome
of intramedullary spinal cord tumours: Experience with 18 patients operated
at Ayub Teaching Hospital, Abbottabad. J Ayub Med Coll Abbottabad
2010;22:15‑7.
Boström A, Kanther NC, Grote A, Boström J. Management and outcome
in adult intramedullary spinal cord tumours: A 20‑year single institution
experience. BMC Res Notes 2014;7:1.
Chang UK, Choe WJ, Chung SK, Chung CK, Kim HJ. Surgical outcome
and prognostic factors of spinal intramedullary ependymomas in adults.
J Neurooncol 2002;57:133‑9.
Cohen AR, Wisoff JH, Allen JC, Epstein F. Malignant astrocytomas of the
spinal cord. J Neurosurg 1989;70:50‑4.
Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision
of intramedullary spinal cord tumors: Surgical morbidity and long‑term follow‑up
evaluation in 164 children and young adults. J Neurosurg 2000;93:183‑93.
Costa P, Bruno A, Bonzanino M, Massaro F, Caruso L, Vincenzo I, et al.
Somatosensory‑and motor‑evoked potential monitoring during spine and
spinal cord surgery. Spinal Cord 2007;45:86‑91.
Isaacson SR. Radiation therapy and the management of intramedullary spinal
cord tumors. J Neurooncol 2000;47:231‑8.
Klekamp J, Samii M. Surgery of spinal tumors. Berlin – Heidelberg: Springer;
2007.

S622

13.
14.

15.

16.

17.

18.

19.

20.

Kothbauer KF, Deletis V, Epstein FJ. Motor‑evoked potential monitoring
for intramedullary spinal cord tumor surgery: Correlation of clinical and
neurophysiological data in a series of 100 consecutive procedures. Neurosurg
Focus 1998;4:E3.
Kumar R, Banerjee S. Management and functional outcome of intramedullary
spinal cord tumors: A prospective clinical study. Asian J Neurosurg
2014;9:177.
Manzano G, Green BA, Vanni S, Levi AD. Contemporary management of
adult intramedullary spinal tumors—Pathology and neurological outcomes
related to surgical resection. Spinal Cord 2008;46:540‑6.
Matsuyama Y, Sakai Y, Katayama Y, Imagama S, Ito Z, Wakao N, et al.
Surgical results of intramedullary spinal cord tumor with spinal cord
monitoring to guide extent of resection: Clinical article. J Neurosurg
2009;10:404‑13.
McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma
of the spinal cord. J Neurosurg 1990;72:523‑32.
Morota N, Deletis V, Constantini S, Kofler M, Cohen H, Epstein FJ. The role
of motor evoked potentials during surgery for intramedullary spinal cord
tumors. Neurosurgery 1997;41:1327‑36.
Nakamura M, Ishii K, Watanabe K, Tsuji T, Takaishi H, Matsumoto M, et al.
Surgical treatment of intramedullary spinal cord tumors: Prognosis and
complications. Spinal Cord 2008;46:282‑6.
Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G. Long‑term
follow‑up of intramedullary spinal cord tumors: A series of 202 cases.
Neurosurgery 2005;56:972‑81.
Sala F, Bricolo A, Faccioli F, Lanteri P, Gerosa M. Surgery for intramedullary
spinal cord tumors: The role of intraoperative (neurophysiological)
monitoring. Eur Spine J 2007;16:130‑9.
Sandalcioglu I, Gasser T, Asgari S, Lazorisak A, Engelhorn T, Egelhof T, et al.
Functional outcome after surgical treatment of intramedullary spinal cord
tumors: Experience with 78 patients. Spinal Cord 2005;43:34‑41.
Schwartz TH, McCormick PC. Intramedullary ependymomas: Clinical
presentation, surgical treatment strategies and prognosis. J Neurooncol
2000;47:211‑8.
Sevick RJ, Wallace CJ. MR imaging of neoplasms of the lumbar spine. Magn
Reson Imaging Clin N Am 1999;7:539‑53.

